» Articles » PMID: 21841290

Prevalence of HCV Risk Behaviors Among Prison Inmates: Tattooing and Injection Drug Use

Overview
Date 2011 Aug 16
PMID 21841290
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis C virus (HCV) is the most common blood-borne chronic viral infection in the United States and it is over represented in incarcerated populations. This study estimates if in prison tattooing is associated with self reported HCV infection in a probabilistic sample of 1,331 sentenced inmates in Puerto Rico prisons anonymously surveyed in 2004, who had previously been tested for HCV. Analysis were carried out with the total sample and among non-injectors (n=796) to control for injection drug use (IDU) and other confounders. Nearly 60% of inmates had acquired tattoos in prison. HCV was reported by 27% of subjects in the total sample and by 12% of non-injectors who had undergone tattoos in prison. IDU was the strongest predictor of HCV in the total sample (OR=5.6, 95% CI=3.2-9.7). Among non injectors, tattooing with reused needles or sharp objects and/ or reusing ink was positively associated with HCV self-report (OR=2.6, 95% CI=1.3-5.5). Tattooing is a common occurrence in this prison setting. Findings suggest that preventive interventions are required to reduce the risk of HCV transmission through unsterile tattooing and injection practices.

Citing Articles

The Efficacy of On-Site Integration Screening and Microelimination Programs for Chronic Hepatitis C in a Detection Center: A Comparison of the Treatment Outcomes and Characteristics of Incarcerated Patients and Outpatients.

Chang H, Wang S, Kuo H, Sheu M, Feng I, Ho C Int J Hepatol. 2024; 2024:3184892.

PMID: 38510786 PMC: 10954363. DOI: 10.1155/2024/3184892.


Dermatological and Ophthalmological Inflammatory, Infectious, and Tumoral Tattoo-Related Reactions: A Systematic Review.

Munoz-Ortiz J, Gomez-Lopez M, Echeverry-Hernandez P, Ramos-Santodomingo M, de-la-Torre A Perm J. 2022; 25.

PMID: 35348060 PMC: 8817925. DOI: 10.7812/TPP/20.225.


The global and regional prevalence of hepatitis C and B co-infections among prisoners living with HIV: a systematic review and meta-analysis.

Gharaei H, Fararouei M, Mirzazadeh A, Sharifnia G, Rohani-Rasaf M, Bastam D Infect Dis Poverty. 2021; 10(1):93.

PMID: 34210349 PMC: 8252262. DOI: 10.1186/s40249-021-00876-7.


Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.

Crowley D, Murtagh R, Cullen W, Keevans M, Laird E, McHugh T Harm Reduct J. 2019; 16(1):42.

PMID: 31277665 PMC: 6612120. DOI: 10.1186/s12954-019-0313-7.


Hepatitis C virus screening and treatment in Irish prisons from nurse managers' perspectives - a qualitative exploration.

Crowley D, Van Hout M, Murphy C, Kelly E, Lambert J, Cullen W BMC Nurs. 2019; 18:23.

PMID: 31210751 PMC: 6567378. DOI: 10.1186/s12912-019-0347-x.


References
1.
Stein J, Nyamathi A . Correlates of hepatitis C virus infection in homeless men: a latent variable approach. Drug Alcohol Depend. 2004; 75(1):89-95. DOI: 10.1016/j.drugalcdep.2004.02.002. View

2.
Jain M, Chakravarti A, Verma V, Bhalla P . Seroprevalence of hepatitis viruses in patients infected with the human immunodeficiency virus. Indian J Pathol Microbiol. 2009; 52(1):17-9. DOI: 10.4103/0377-4929.44955. View

3.
Jurgens R, Ball A, Verster A . Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infect Dis. 2008; 9(1):57-66. DOI: 10.1016/S1473-3099(08)70305-0. View

4.
Singer M, Younossi Z . Cost effectiveness of screening for hepatitis C virus in asymptomatic, average-risk adults. Am J Med. 2002; 111(8):614-21. DOI: 10.1016/s0002-9343(01)00951-2. View

5.
Armstrong G, Wasley A, Simard E, McQuillan G, Kuhnert W, Alter M . The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006; 144(10):705-14. DOI: 10.7326/0003-4819-144-10-200605160-00004. View